News

Brazilian PTO (BRPTO) publishes Resolution 217/2018 regarding the fast-track examination of pharma-related patent applications and patents

The Industrial Property Gazette (RPI) 2470 published Resolution 217, which amended Resolution 80 of 2013. Therefore, since May 8, 2018, patent applications related to pharmaceutical products and processes (as well as equipment and materials used in these areas) related to Zika and Chikungunya have also become part of the list of patents related to neglected diseases that benefit from the fast track examination before Brazilian Patent and Trademark Office (BRPTO).

The new Resolution has also included applications for rare diseases, classified by the World Health Organization (WHO) and by Brazilian guidelines for treatments under the National Healthcare System (SUS), as diseases which affect up to 65 people per 100,000 subjects or 1,3 people per 2,000 subjects.

Additionally, an important point included in the new Resolution 217 was that also patents already granted could benefit from the fast track examination in the BRPTO’s Appeal instance.

It should be pointed out that this measure demonstrates the BRPTO's alignment with the public health care policies of the Brazilian Ministry of Health and with the development of the industrial complex in the area of ??Health.

Home News Brazilian PTO (BRPTO) publishes Resolution 217/2018 regarding the fast-track examination of pharma-related patent applications and patents

Rio de Janeiro - RJ

Av. Rio Branco, 103
11º (recepção) e 12º andares
20040-004 - Rio de Janeiro, RJ - Brasil
Tel.: +55 (21) 2221-3757
Fax: +55 (21) 2224-7169
bhe@bheringadvogados.com.br

São Paulo - SP

Av. Doutor Cardoso de Melo, 900
9º andar
04548-003 - São Paulo, SP - Brasil
Tel.: +55 (11) 5505-1191
Fax: +55 (11) 5505-1295
bhe-sp@bheringadvogados.com.br

Curitiba - PR

Av. Sete de Setembro, 4615
15º andar
80240-000 - Curitiba, PR - Brasil
Tel.: +55 (41) 3015-9399
Fax: +55 (41) 3014-7399
bhe-pr@bheringadvogados.com.br